Thornburg Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-97,490
Closed -$10.9M 178
2020
Q2
$10.9M Hold
97,490
0.14% 100
2020
Q1
$8.75M Buy
97,490
+104
+0.1% +$9.34K 0.13% 103
2019
Q4
$10.5M Sell
97,386
-54
-0.1% -$5.84K 0.1% 116
2019
Q3
$9.54M Sell
97,440
-160
-0.2% -$15.7K 0.09% 118
2019
Q2
$12.8M Sell
97,600
-10,284
-10% -$1.35M 0.12% 106
2019
Q1
$14.6M Sell
107,884
-24,817
-19% -$3.35M 0.14% 99
2018
Q4
$12.9M Buy
132,701
+5
+0% +$487 0.13% 108
2018
Q3
$18.4M Buy
132,696
+15,144
+13% +$2.11M 0.15% 104
2018
Q2
$14.6M Buy
117,552
+378
+0.3% +$46.9K 0.11% 155
2018
Q1
$13.1M Buy
117,174
+663
+0.6% +$73.9K 0.1% 158
2017
Q4
$13.9M Buy
116,511
+14,911
+15% +$1.78M 0.1% 154
2017
Q3
$14.3M Sell
101,600
-10
-0% -$1.4K 0.1% 150
2017
Q2
$12.4M Sell
101,610
-16
-0% -$1.95K 0.09% 164
2017
Q1
$12.3M Buy
101,626
+179
+0.2% +$21.7K 0.1% 158
2016
Q4
$12.4M Sell
101,447
-31,576
-24% -$3.86M 0.1% 161
2016
Q3
$16.3M Buy
133,023
+164
+0.1% +$20.1K 0.12% 141
2016
Q2
$15.5M Buy
132,859
+8,688
+7% +$1.01M 0.12% 148
2016
Q1
$17.3M Buy
124,171
+9,305
+8% +$1.3M 0.12% 156
2015
Q4
$21.9M Buy
114,866
+244
+0.2% +$46.5K 0.14% 145
2015
Q3
$17.9M Sell
114,622
-5,532
-5% -$865K 0.11% 155
2015
Q2
$21.7M Hold
120,154
0.13% 153
2015
Q1
$20.8M Buy
120,154
+25,580
+27% +$4.43M 0.12% 169
2014
Q4
$17.5M Sell
94,574
-18,241
-16% -$3.38M 0.09% 201
2014
Q3
$18.7M Buy
112,815
+5,504
+5% +$913K 0.08% 193
2014
Q2
$16.8M Buy
107,311
+18,266
+21% +$2.85M 0.07% 200
2014
Q1
$13.5M Sell
89,045
-60,367
-40% -$9.18M 0.05% 206
2013
Q4
$19.9M Sell
149,412
-14,022
-9% -$1.86M 0.08% 175
2013
Q3
$19M Sell
163,434
-12,779
-7% -$1.48M 0.08% 177
2013
Q2
$16.3M Buy
+176,213
New +$16.3M 0.07% 171